Cancer Drug Patent Rejected In India

By: Associated Press
By: Associated Press

A lawyer for healthcare activists says India's Supreme Court has rejected drug maker Novartis AG's right to patent a new version of a lifesaving cancer drug.

The landmark ruling Monday is a victory for India's $26 billion generic drug industry that provides cheap medicines to millions around the world.

The ruling is a precedent that prevents international pharmaceutical companies from obtaining fresh patents in India on updated versions of existing drugs.

Lawyer Anand Grover said such a ruling would help poor people get access to affordable, generic versions of lifesaving medicines.

Novartis has fought a legal battle in India since 2006 for a fresh patent for a leukemia drug.

India's patent office had rejected the company's patent application because it was not a new medicine.

Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus

275 E. Arlington Blvd. Greenville, NC 27858 252-439-7777
Copyright © 2002-2015 - Designed by Gray Digital Media - Powered by Clickability 200826511 -
Gray Television, Inc.